Atlas Trials

Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers

Clinical trial NCT01348737 · COMPLETED

Trial details

NCT number
NCT01348737
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's DiseaseSafetyTolerabilityBlood ConcentrationHealthy Volunteers
Start date
2011-06-01
Primary completion
2011-11-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.